Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?

Patrik Brundin, Roger Olsson

Research output: Contribution to journalArticlepeer-review

8 Citations (SciVal)
Original languageEnglish
Pages (from-to)917-919
JournalExpert Review of Neurotherapeutics
Issue number7
Publication statusPublished - 2011

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Neuronal Survival (013212041)

Subject classification (UKÄ)

  • Neurosciences

Cite this